NKRF activators, in the context of this list, refer primarily to chemicals that indirectly influence the activity of NKRF through modulation of the NF-kappa-B pathway. NKRF, being a repressor, does not have direct activators in the conventional sense. However, the chemicals listed play a crucial role in modulating the NF-kappa-B signaling pathway, which is intimately connected with the regulatory functions of NKRF. The primary mechanism by which these chemicals can be considered as NKRF activators is through their inhibition or modulation of NF-kappa-B activity. NF-kappa-B is a critical transcription factor involved in inflammatory responses, immune function, and cell survival. Inhibitors of NF-kappa-B, like Sulfasalazine and Parthenolide, can potentially enhance the repressive effect of NKRF on NF-kappa-B by reducing its activation or nuclear translocation. This indirect enhancement of NKRF's activity is crucial in contexts where NF-kappa-B overactivation is detrimental.
Moreover, these chemicals exhibit diverse pharmacological properties, affecting various aspects of NF-kappa-B signaling. For instance, compounds like Curcumin and Resveratrol not only inhibit NF-kappa-B but also possess antioxidant and anti-inflammatory properties. This multifaceted approach can be beneficial in regulating the NF-kappa-B/NKRF axis in complex cellular environments. The alteration of NKRF dynamics through these chemicals can be particularly relevant in research settings where understanding the intricate balance between NF-kappa-B activation and repression is crucial.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sulfasalazine | 599-79-1 | sc-204312 sc-204312A sc-204312B sc-204312C | 1 g 2.5 g 5 g 10 g | $61.00 $77.00 $128.00 $209.00 | 8 | |
Inhibits NF-kappa-B activation, potentially increasing NKRF activity by reducing competitive inhibition. | ||||||
Parthenolide | 20554-84-1 | sc-3523 sc-3523A | 50 mg 250 mg | $81.00 $306.00 | 32 | |
Targets NF-kappa-B signaling, potentially altering NKRF dynamics by modifying pathway activity. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
Inhibits NF-kappa-B activation, potentially enhancing NKRF's repressive effect. | ||||||
Anacardic Acid | 16611-84-0 | sc-202463 sc-202463A | 5 mg 25 mg | $102.00 $204.00 | 13 | |
Inhibits NF-kappa-B activation, may indirectly promote NKRF activity. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Inhibits NF-kappa-B, possibly supporting NKRF's repressive role. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Modulates NF-kappa-B pathway, potentially impacting NKRF activity. | ||||||
Andrographolide | 5508-58-7 | sc-205594 sc-205594A | 50 mg 100 mg | $15.00 $40.00 | 7 | |
Inhibits NF-kappa-B, may enhance NKRF repression. | ||||||
Emodin | 518-82-1 | sc-202601 sc-202601A sc-202601B | 50 mg 250 mg 15 g | $105.00 $214.00 $6255.00 | 2 | |
Affects NF-kappa-B signaling, possibly influencing NKRF activity. | ||||||
Piperlongumine | 20069-09-4 | sc-364128 | 10 mg | $107.00 | ||
Inhibits NF-kappa-B, potentially impacting NKRF function. | ||||||
Caffeic acid phenethyl ester | 104594-70-9 | sc-200800 sc-200800A sc-200800B | 20 mg 100 mg 1 g | $71.00 $296.00 $612.00 | 19 | |
Inhibits NF-kappa-B, potentially enhancing NKRF's repressive role. | ||||||